Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitisIkki Sakuma, Gerald I. Shulman, Dean Yimlamai et al.|Proceedings of the National Academy of Sciences|2025Cited by 33
TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemiaHiroaki Ochiiwa, Tomoaki Tanaka|Oncogene|2021Cited by 31
Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing’s disease: a case reportTomoko Takiguchi, Tomoaki Tanaka|BMC Endocrine Disorders|2017Cited by 11
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitisIkki Sakuma, Gerald I. Shulman, Rafael Calais Gaspar et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
Hepatic ferredoxin reductase modulates mitochondrial function and iron homeostasis in metabolic dysfunction-associated steatotic liver diseaseTomoaki Tanaka, Gerald I. Shulman|Research Square|2025Cited by 0